glp-1 agonists medications America's Poison Centers How does Ozempic work? The

Why Are GLP-1 Medications Being Discussed

There do not appear to be any other ongoing large kidney outcome trials researching GLP-1 receptor agonists or newer dual or triple agonists, but it will be exciting to see in the future the results of smaller ongoing trials and hopefully additional large prospective clinical trials with kidney outcomes

Bruyre O, et al

Under the terms of the deal, the pharmaceutical giant will pay Gubra $350 million upfront

"Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes"

Randomized controlled trials are necessary to validate if GLP-1 RAs genuinely enhance the health of these patients and to ensure their safety